Effects of 5 alpha-reductase inhibition by finasteride on lipoproteins and body composition in males affected by benign prostatic hyperplasia (BPH)
Denti, L.; Pasolini, G.; Cortellini, P.; Sanfelici, L.; Benedetti, R.; Cecchetti, A.; Ferretti, S.; Banchini, A.; Ablondi, F.; Valenti, G.
Journal of Endocrinological Investigation 22(10 Suppl): 70-71
1999
ISSN/ISBN: 0391-4097 PMID: 10727053 Document Number: 500734
Document emailed within 1 workday
Related Documents
Hansen, B.J.; Hvidt, V. 1993: Finasteride. a new 5 alpha reductase inhibitor registered for treatment of benign prostatic hypertrophy with the purpose of avoiding or postponing surgery Ugeskrift for Laeger 155(50): 4110-4112Djavan, B.; McConnell, J. 1996: The effect of 5-alpha-reductase inhibitors on benign prostatic hyperplasia Wiener Medizinische Wochenschrift 146(8): 165-168
Yu, H.J.; Chiu, T.Y.; Lai, M.K. 1995: Therapeutic effects of finasteride in benign prostatic hyperplasia: a randomized double-blind controlled trial Journal of the Formosan Medical Association 94(1-2): 37-41
Sun, Z.Y.; Tu, Z.H. 1998: A novel in vitro model to screen steroid 5 alpha-reductase inhibitors against benign prostatic hyperplasia Methods and Findings in Experimental and Clinical Pharmacology 20(4): 283-287
Granados Loarca, E.A. 1999: Medical treatment of benign prostatic hyperplasia. The efficacy of finasteride depends on prostatic volume Archivos Espanoles de Urologia 52(3): 201-208
Ekman, P.; Andersen, J.T.; Wolf, H. 1996: Finasteride in the treatment of benign prostatic hyperplasia Acta Urologica Belgica 64(1): IX-XII
Trinkler, F.B. 1997: Therapy of benign prostatic hyperplasia: terazosin or finasteride? Praxis 86(34): 1305-1306
Wu, T.T.; Lee, Y.H.; Jiaan, B.P.; Huang, J.K. 1995: The efficacy of finasteride in the treatment of symptomatic benign prostatic hyperplasia Zhonghua Yi Xue Za Zhi 56(6): 399-403
Magoha, G.A. 1998: Finasteride in the treatment of patients with moderate symptoms of benign prostatic hyperplasia East African Medical Journal 75(5): 260-263
Anwarul Islam, A.K.M.; Kashem, M.A.; Shameem, I.A.; Kibria, S.A.M.G. 2005: Efficacy of terazosin and finasteride in symptomatic benign prostatic hyperplasia: a comparative study Bangladesh Medical Research Council Bulletin 31(2): 54-61
Tveter, K.J.; Beisland, H.O.; Andersen, J.T.; Wolf, H.; Ekman, P.; Johansson, J.E.; Kontturi, M.; Lehtonen, T. 1996: Treatment of benign prostatic hyperplasia with Proscar (finasteride). Results of a 10-year Scandinavian study Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 116(27): 3226-3230
Spivak, L.G.; Lokshin, K.L.; Vinarov, A.Z. 2015: Review of Clinical Studies on Combination Therapy of 5α-Reductase Inhibitors and Α1-Blockers in Patients with Benign Prostatic Hyperplasia Urologiia 2015(4): 125-133
Drsata, J. 2002: Enzyme inhibition in the drug therapy of benign prostatic hyperplasia Casopis Lekaru Ceskych 141(20): 630-635
Lepor, H. 1995: Alpha blockade for the treatment of benign prostatic hyperplasia Urologic Clinics of North America 22(2): 375-386
Lowenthal, D.T.; Flannery, M.; Mader, S.L.; Nelson, R.P. 1998: Benign prostatic hyperplasia: maximizing treatment with alpha blockers Geriatrics 53(Suppl 2): S4-28
Jonas, U.; Melchior, H.; Rübben, H. 1998: Recommendations for billing alternative therapy of benign prostatic hyperplasia. Laser therapy of benign prostatic hyperplasia Der Urologe. Ausg. a 37(1): 110-111
Gao, W.-J.; Wang, Y.-M.; Wang, C.-H.; Yang, X.-K.; Wan, L.; Li, W.-P. 2013: Expressions of SIgA and alpha 1-AR in benign prostatic hyperplasia combined with chronic prostatitis and their implications Zhonghua Nan Ke Xue 19(4): 315-320
Matsumoto, S.; Uemura, H. 2008: Examination of the mechanism of ameliorating effect of alpha 1-blocker on storage symptoms associated with benign prostatic hyperplasia Hinyokika Kiyo. Acta Urologica Japonica 54(6): 453-456
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Tomita, M.; Egawa, S.; Ikemoto, I.; Nakajo, H.; Hatano, T.; Kira, S.; Mizuo, T.; Kagami, Y. 2009: One-week effects of Tamsulosin on benign prostatic hyperplasia assessed with a daily symptom score Hinyokika Kiyo. Acta Urologica Japonica 55(4): 193-197